Home › Myotonic Dystrophy › Virginia
Myotonic Dystrophy clinical trials in Virginia
8 studies for Myotonic Dystrophy are looking for participants at sites in Virginia.
Cities in Virginia
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
- Virginia Commonwealth University - Biotech One, Richmond
RecruitingPhase 3
Ages 16 and older · All sexes · Updated Sep 25, 2026 · NCT07486934A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1
- Virginia Commonwealth University Medical Center- Site Number : 8400006, Richmond
RecruitingPhase 1/2
Ages 10 to 55 · All sexes · Updated Sep 21, 2026 · NCT06844214Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension
- Virginia Commonwealth University, Richmond
RecruitingObservational study
Ages 18 to 70 · All sexes · Updated Sep 4, 2026 · NCT07700225Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension
- Virginia Commonwealth University, Richmond
RecruitingObservational study
Ages 3 to 17 · All sexes · Updated Aug 11, 2026 · NCT06747884DMCRN-02-001: Assessing Pediatric Endpoints in DM1
- Virginia Commonwealth University, Richmond
RecruitingObservational study
59 Months · All sexes · Updated Jun 10, 2026 · NCT05224778Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
- Virginia Commonwealth University, Richmond
RecruitingObservational study
Ages 18 to 70 · All sexes · Updated Jun 10, 2026 · NCT03981575Study of ATX-01 in Participants With DM1
- Virginia Commonwealth University, Richmond
RecruitingPhase 1/2
Ages 18 to 64 · All sexes · Updated Feb 10, 2026 · NCT06300307Long-Term Development of Muscular Dystrophy Outcome Assessments
- Virginia Commonwealth University, Richmond
RecruitingObservational study
Ages 6 to 50 · All sexes · Updated Nov 18, 2025 · NCT05989620From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.